Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at BAY 2927088 as a treatment for non small cell lung cancer that has spread

Overview

Cancer types:

Lung cancer, Non small cell lung cancer (NSCLC), Secondary cancers

Status:

Open

Phase:

Phase 3

Details

This trial is comparing with a new drug called BAY 2927088 as a first treatment for non small lung cell lung cancer.

It is for people with non small cell lung cancer who:

  • have a change () in a called HER2

  • have not had treatment for their cancer

Recruitment start: 28 August 2024

Recruitment end: 17 April 2026

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Ajay Mehta

Supported by

Bayer

Last reviewed: 29 April 2025

CRUK internal database number: 19965

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.